Bundle Blocks 2

Knowledge-Based Comprehensive Cancer Care

Generate comprehensive and personalized care plans in real time with our cognitive computing platform.

A comprehensive care plan is not a one-time recommendation. It's about building and managing a comprehensive plan with care that is inferenced continuously. 

Our EyeLlation™ hybrid inference engine combines patient-specific data with expert codified knowledge to create actionable, patient-specific treatment plans with nationally-accepted standards and the latest genomic-based considerations.

Bundle Blocks 1

Cognitive Computing Platform

VieCure unveils its cognitive computing platform with codified expert knowledge and real-time comprehensive and personalized care plans.  Our EyeLlation™ hybrid inference engine combines data, knowledge and technology to offer optimal personalized care in seconds. 

We codified knowledge in nationally-recognized standards and molecular oncology considerations, including genomic-based targeted therapies, immunotherapies and complex combination treatments.

Our platform was designed as a true 21st century clinical peer-to-peer knowledge transfer platform where physicians can get immediate access to standards of care and expert knowledge personalized to the specific patient being treated.

Clinicians can access the best clinical knowledge in real time to create actionable, patient-specific treatment plans that cover history, schedule, drugs, toxicities, interactions, and genomic-guided considerations. Patient-reported medication and toxicity tracking allows clinicians to monitor and proactively manage side effects and symptoms.

Bundle Blocks 2

VieCure and Avera Health Confirm Clinical Validation and System-Wide Implementation of Cognitive Computing Platform

VieCure and Avera Health announced that the VieCure's cognitive computing platform will be fully implemented across the multi-state cancer system. The platform was developed through a clinical collaboration between the two organizations.

VCurePrecision™ is a cognitive computing platform that generates comprehensive and personalized treatment plans in a matter of seconds.

Through the EyeLlation™ custom hybrid inference engine, the platform combines patient-specific diagnostic, surgical and demographic data from the electronic medical record (EMR) with genomic and tumor sequencing information (when available) to generate personalized treatment plans that comply with nationally recognized guidelines and the latest considerations in precision medicine.

Bundle Blocks 1

Patient Engagement Mobile App

Our patient mobile app is interactive with the ability for patients to better manage their care and communication with their care team. 

  • Mobile medication tracking and reminders
  • Simple communication with care team
  • Self-manage care and report side effects
  • Automatic scheduling reminders
  • Dynamic and real-time patient connection

Our mobile app facilitates engagement between patients and their care team and provides patients with easy access to  important details for current treatment and ongoing survivorship needs.

Conferences and Events

Precision Medicine World Conference
January 22-24, 2018
Silicon Valley

Dr. Fred Ashbury will present at the 2018 Precision Medicine World Conference in Silicon Valley. Dr. Ashbury will be part of the Clinical Dx Showcase to address cognitive computing in oncology. 

Matt's Story

Matt is lung cancer survivor (8 years and counting) because of genomic testing and a personalized treatment strategy.

As the Founder/CEO of SURVIVEiT®, he believes it is vital for patients to take control of their care and develop a treatment plan that is specific to their cancer.

Learn more about Matt’s personal battle with cancer and his passion for helping patients to advocate for the best care available.

Know What is Driving Your Cancer

Dr. Brian Leyland-Jones explains why each cancer patient must insist on having his or her tumor sequenced to find out what genetic alterations are driving his or her cancer.

When you know the genomics behind your cancer and the treatments available, you can work with your doctor to determine a treatment strategy specific to you.

VieCure News